News - EAPM

last published

Dublin Conference Examines the Path from Innovation to Patient Access

Dublin, 2 October 2026 – The European Alliance for Personalised Medicine (EAPM) & The Irish Patients Association brought together stakeholders from across healthcare, research, industry, patient organisations and policy in Dublin on October 2nd to examine how Europe can move personalised medicine from scientific and technological innovation towards routine, equitable

NEWS

Latest updates

Be informed and stay informed on all
news, events and publication updated.

ON-COME Launches European Survey to Map Psychosocial and Supportive Care in Paediatric Oncology

ON-COME General Assembly to Bring Partners Together in Madrid for the Next Phase of Holistic Paediatric Cancer Care

iBeCHANGE Stakeholder Roundtable Explores Pathways Towards Sustainable Cancer Prevention

Personalised Medicine Moves Up the Policy Agenda: From Scientific Promise to Health-System Readiness

ESMO 2026: Advancing Access to Personalised Oncology

Global Trials, Local Relevance: A Scientific and Regulatory Framework for Regional Enrollment in Cancer Drug Development

SYNTHIA Survey on Synthetic Data in Healthcare

Focus on TOP 2026: Advancing Translational Oncology and Precision Medicine in Breast Cancer

EVENTS

Let's get together

Be informed and stay informed on all
news, events and publication updated.

ON-COME General Assembly to Bring Partners Together in Madrid for the Next Phase of Holistic Paediatric Cancer Care

Madrid, 19 October 2026 – One year after the launch of the ON-COME project in Rome, partners from across Europe will come together in Madrid

EAPM Conference on Personalised Medicine Access in Dublin During the Irish Presidency

Dublin, 2 October 2026 — The European Alliance for Personalised Medicine will convene a high-level conference in Dublin on 2 October 2026, bringing together policymakers,

ESMO 2026: Advancing Access to Personalised Oncology

The European Alliance for Personalised Medicine will convene a dedicated ESMO session on “Personalised Oncology Across Health Systems: From Molecular Insight to Measurable Access” on

EAPM Contributes to Strategic Alignment at JA PCM Kick-Off Meeting in Brussels

The European Alliance for Personalised Medicine (EAPM) participated in the Kick-Off Meeting of the Joint Action on Personalised Cancer Medicine (JA PCM) in Brussels, as

EAPM in Berlin: Advancing Precision Oncology from Dialogue to Delivery

On 17–18 October 2025 in Berlin, the European Alliance for Personalised Medicine (EAPM) convened two key events aimed at accelerating the practical implementation of precision

EAPM Participates in ON-COME Kick-Off in Rome: Advancing Holistic Care Pathways for Children with Cancer

The European Alliance for Personalised Medicine (EAPM) was pleased to participate and present at the official kick-off meeting of the ON-COME project, held on 6–7

From Policy to Practice: Driving Diagnostic Equity in HER2 Testing at the European Society of Pathology Congress

The European Alliance for Personalised Medicine (EAPM) convened a high-level multi-stakeholder side event during the European Society of Pathology (ESP) Congress in Vienna, bringing together

VISION Europe 2030

2–3 September 2025, Club University Foundation in Brussels, visioneurope2030.com The European Alliance for Personalised Medicine (EAPM) is proud to host the upcoming VISION Europe 2030